trial

Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia

NCTId NCT07404319
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 160 (estimated)
Sponsored by Kit Wa Chan
Primary completion 2028-01-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
160 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Single
Start
2026-02-23
Primary completion
2028-01-30
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Aerobic exerciseActive TDCS

Sponsors

Kit Wa ChanLead Sponsor

Investigators

1
Kit Wa Chan, MDPrincipal Investigator

Sites

1 total
Hong Kong, Hong Kong

Facts & assertions

4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2028-01-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Aerobic exercise
drug
Active TDCS
drug
lead_sponsor
Kit Wa Chan
company
indication
Treatment Resistant Schizophrenia
indication
Cognitive Dysfunction
indication
Schizophrenia
indication
investigator
Kit Wa Chan, MD
person